Navigation Links
Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
Date:9/18/2007

New Minimally Invasive Procedure for Treating Major Symptoms of Lumbar

Spinal Stenosis

SUNNYVALE, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Kyphon Inc. (Nasdaq: KYPH) today announced that Dr. Michael Marks, orthopaedic spine surgeon from Coastal Orthopedics in Norwalk, Connecticut, and Julie Tracy, Kyphon's chief communications officer, will be interviewed together on American Health Radio, the nationally-syndicated health radio program hosted by Scott Broder. The program will include questions from listeners on the role of the X-STOP(R) Interspinous Process Decompression (IPD(R)) procedure to treat the symptoms of lumbar spinal stenosis.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/kyphon/29766/

During the show, Dr. Marks will discuss the treatment options available to patients suffering from lumbar spinal stenosis, including the X-STOP(R) implant, the first interspinous process spacer approved in the U.S. for treating the symptoms of lumbar spinal stenosis. Symptoms from lumbar spinal stenosis often limit a patient's self-supporting daily activities, work, and social and recreational pursuits. Using a minimally invasive surgical procedure to place the X-STOP(R) implant, symptoms may be relieved, and patients may return to a more active lifestyle.

The program will air live at 6:00 p.m. Central Time on Monday, September 24, 2007 and can be accessed at http://www.wrmn1410.com. A replay of the program will be available on Wednesday, September 26 at 8:00 p.m. Central Time and on Friday, September 28 at 6:00 p.m. Central Time. Repeat broadcasts will also be available at http://www.healthradionetwork.com.

About the X-STOP(R) IPD(R) Procedure

The X-STOP(R) IPD(R) procedure represents a new approach to treating the symptoms of lumbar spinal stenosis or LSS. LSS is a common spinal problem suffered mainly by the middle-aged and elderly population and results from a narrowing in the lumbar spinal canal that carries nerves to the legs. As this space in the lower spine shrinks, nerves are squeezed causing debilitating pain in the back and legs.

The X-STOP(R) implant is the first approved Interspinous Process Spacer in the U.S. to treat the symptoms of LSS. It is designed to limit extension of the lumbar spine and keep the canal open in the lower spine that carries nerves to the legs thereby relieving pain associated with the narrowing of the canal.

The unique design of the X-STOP(R) implant enables it to be inserted using a minimally invasive approach, without fixation to bones or ligaments. Due to its minimally invasive nature, the procedure can typically be performed in 45 to 90 minutes.

According to an independent market research organization, there are approximately 1.4 million individuals in the United States with a primary or secondary diagnosis of lumbar spinal stenosis. The X-STOP(R) IPD(R) procedure may be a treatment alternative for approximately 220,000 of these individuals who would have otherwise been treated with conservative non-operative therapies or with a surgical procedure called a laminectomy.

About Kyphon Inc.

Kyphon develops and markets medical devices designed to restore and preserve spinal function and diagnose the source of low back pain using minimally invasive technologies. The company's products are used in balloon kyphoplasty for the treatment of spinal fractures caused by osteoporosis or cancer, in the Functional Anaesthetic Discography(TM) (F.A.D.(TM)) procedure for diagnosing the source of low back pain, and in the Interspinous Process Decompression (IPD(R)) procedure for treating the symptoms of lumbar spinal stenosis. More information about the company and its products can be found at http://www.kyphon.com and its balloon kyphoplasty patient education Web site, http://www.spinalfracture.com. Functional Anaesthetic Discography and F.A.D. are trademarks, and Kyphon,

X-STOP, and IPDare registered trademarks, of Kyphon Inc.


'/>"/>
SOURCE Kyphon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Composite fillings to hasten work procedures
3. Benefits in fertility procedures
4. Brain aneurysms can now be treated with a less invasive procedure
5. New virtual colonoscopy procedure for easier colon screening
6. Dental Procedure Reduces Preterm Births
7. New Kidney Transplantation procedure
8. Hypnosis Found To Reduce Stress In Children During Medical Procedures
9. Survival rate not improved by invasive procedures
10. Improved procedure to do laproscopic esophagectomy discovered
11. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: